The flat-rate model means you can focus on finding your effective dose without financial anxiety about escalating charges
Rise slowly from a lying or sitting position
A licensed registered nurse can add a B12 shot to your visit or come just for the injection, anywhere across Greater Sacramento
Doses up to 1,000 mcg, though unnecessary, aren't harmful
FDA rejection and regulatory status Development timeline: 2000s: Developed for Parkinson's/Alzheimer's 2008: Phase 2 obesity trials (successful) 2010: Phase 3 trials initiated 2010: Development halted due to safety concerns 2012: FDA rejected obesity indication Present: No approved indication anywhere Why FDA rejected: Cardiovascular safety concerns primary reason Increased heart rate and blood pressure Risk-benefit ratio unfavorable Safer alternatives available ( GLP-1 agonists ) Development company abandoned pursuit No current path to approval Regulatory status by country: Current legal classification: Not a controlled substance (not scheduled) Not approved for any human use Sold as "research chemical" only "Not for human consumption" labels Legal gray area (enforcement rare) See are peptides legal guide at SeekPeptides
By adhering to the development concept of "symbiosis and win-win", relying on the national science and technology platform, gathering international and domestic leading talents, integrating international leading technology, relying on high-tech superior products and elite team to provide personalized and accurate service, we are helping the global animal husbandry to achieve green and low cost
